Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4632411000168113 | Aprepitant (SCP) (aprepitant 165 mg) capsule, 1 capsule, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4632421000168118 | Aprepitant (SCP) 165 mg capsule, 1, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aprepitant (SCP) 165 mg capsule, 1, blister pack | Is a | Aprepitant (SCP) 165 mg capsule, 1 | true | Inferred relationship | Some | ||
| Aprepitant (SCP) 165 mg capsule, 1, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Aprepitant (SCP) 165 mg capsule, 1, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Aprepitant (SCP) 165 mg capsule, 1, blister pack | has TP | Aprepitant (SCP) | true | Inferred relationship | Some | ||
| Aprepitant (SCP) 165 mg capsule, 1, blister pack | has TPUU | Aprepitant (SCP) 165 mg capsule | true | Inferred relationship | Some | 582368357 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR